Global Dermal Toxicity Testing Market Size To Exceed USD 4.95 Billion By 2033 | CAGR of 8.11% [Yahoo! Finance]
Qiagen N.V. Common Shares (QGEN)
Last qiagen n.v. common shares earnings: 2/4 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
corporate.qiagen.com/investor-relations
Company Research
Source: Yahoo! Finance
Expected to Reach USD 4.95 Billion by 2033, according to a research report published by Spherical Insights & Consulting. Companies covered: SGS S.A., Eurofins Scientific Inc, Qiagen N.V., Charles River Laboratories International, Inc., Intertek Group, Merck KgaA, Covance, Inc, GE Healthcare, QIMA LTD, Thermo Fisher Scientific, Inc., Catalent, Inc., MatTek Corporation, InVivo Biosystems, and Other Key Vendors. New York, United States , June 14, 2024 (GLOBE NEWSWIRE) -- The Global Dermal Toxicity Testing Market Size is to Grow from USD 2.27 Billion in 2023 to USD 4.95 Billion By 2033, at a Compound Annual Growth Rate (CAGR) during the projected period. Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/4518 Dermal toxicity testing is a type of safety assessment conducted to evaluate the potentially harmful effects of a substance when it comes into contact with the skin, intended to characterize the irritation potential, cutaneous and/or systemic toxicity a
Show less
Read more
Impact Snapshot
Event Time:
QGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QGEN alerts
High impacting Qiagen N.V. Common Shares news events
Weekly update
A roundup of the hottest topics
QGEN
News
- QIAGEN's (QGEN) New QCI Interpret Release Enhances AI Functions [Yahoo! Finance]Yahoo! Finance
- Qiagen (NYSE: QGEN) had its price target raised by analysts at JPMorgan Chase & Co. from $52.00 to $54.00. They now have an "overweight" rating on the stock.MarketBeat
- QIAGEN (QGEN) Debuts dPCR Microbial DNA Detection Assays [Yahoo! Finance]Yahoo! Finance
- QIAGEN announces 2028 strategy for solid profitable growth [Yahoo! Finance]Yahoo! Finance
- QIAGEN announces 2028 strategy for solid profitable growthGlobeNewswire
QGEN
Earnings
- 4/29/24 - Beat
QGEN
Sec Filings
- 6/6/24 - Form 6-K
- 5/31/24 - Form SD
- 5/30/24 - Form S-8
- QGEN's page on the SEC website